my 1250 has been researched along with colforsin in 1 studies
| Studies (my 1250) | Trials (my 1250) | Recent Studies (post-2010) (my 1250) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | my 1250 (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y; Funayama, K; Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N | 1 |
1 other study(ies) available for my 1250 and colforsin
| Article | Year |
|---|---|
Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Animals; Colforsin; Cromolyn Sodium; Exudates and Transudates; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Lung; Male; Peritoneal Cavity; Phosphodiesterase Inhibitors; Quinolones; Rats; Rats, Wistar; Theophylline | 1995 |